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LETTERS TO THE EDITOR
Anabolic Steroid-Induced Echocardiographic
Characteristics of Professional Football Players?
We read with great interest the study by Abernethy et al. entitled
“Echocardiographic Characteristics of Professional Football Play-
ers” (1). The investigators report on a high relative wall thickness
of 0.424, reflecting an emphasis on strength training.
Although the investigators state that “steroid use among the
participants was not known,” no data are presented to underline
this important statement, nor is the possibility of an anabolic
steroid-induced hypertrophy discussed. It is well known that
anabolic steroid use is not uncommon among professional football
players as the National Football League does not perform doping
tests as required by the World Anti-Doping Agency (WADA)
among professional athletes of most other sports. To prove the
investigators’ statement of having examined steroid-free football
players, a screening test for doping substances could have been
performed, or at the least parameters of clinical chemistry which
are altered by the use of anabolic steroids (e.g., follicle-stimulating
hormone, luteinizing hormone, sex-hormone binding globulin,
cholesterol, low-density lipoprotein, high-density lipoprotein, ala-
nine aminotransferase) should have been given in the paper. The
researchers also do not present data on diastolic function, which
may be restricted in anabolic steroid users and thereby contribute
to a differentiation between a physiological and pathological
myocardial hypertrophy (2–5). Furthermore, a description of the
athletes’ training history (years of training, hours per week spent
for strength training) would have been helpful.
As reported previously, the relative wall ratio in anabolic-free
soccer players, rowers, weightlifters, and bodybuilders usually is
about 0.40 and differs significantly from higher values in anabolic
steroid-using bodybuilders (5). This influence of anabolic steroids
on the left ventricular wall has also been demonstrated by others
(2–4,6). Additionally, the cited study of Pelliccia et al. (7) found a
left ventricular wall thickness of 13 mm in only 1.7% (15 rowers
or canoists and 1 cyclist—each of them having a left ventricular
end-diastolic diameter 54 mm) in 947 athletes, whereas Aber-
nethy et al. (1) present about 28% of the football players having a
left ventricular wall thickness of 13 mm in their Figure 2, but
they only mention 11% (17 of 156) with more than 13 mm in the
Results section, which are cited as 6% in the Discussion section of
their study (1).
Furthermore, Abernethy et al. (1) do not cite their used
echocardiographic convention and probably determined myocar-
dial wall thickness by the Penn-Convention (8) (otherwise the use
of the Penn-Cube formula [8] for left ventricular mass determi-
nation is not admissible). Because the Penn-Convention (8)
excludes the epi- and endocard from septal and posterior myocar-
dial wall thickness, an underestimation compared to the data of
Pelliccia et al. (7), who determined the myocardial wall thickness
by use of the convention of the American Society of Echocardi-
ography (9), has to be presumed.
Therefore, we do not share the opinion that the data presented
allow for the conclusion that a strength-training-induced high
relative wall thickness in professional football players reflects a
physiologically induced (concentric) hypertophy.
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REPLY
Dr. Scharhag and colleagues raise the important point that steroid
use among the athletes may have affected echocardiographic
features of presumably healthy elite football players. Anabolic
steroids are commonly used to enhance athletic performance and
muscle development and may have deleterious effects. Hyperten-
sion, ventricular remodeling, myocardial ischemia, and sudden
cardiac death have each been temporally and causally associated
with anabolic steroid use in humans (1). However, studies exam-
ining the effects of anabolic steroids on myocardial structures have
not been consistent, and the topic remains controversial (2,3).
Surveys of U.S. football players at the high school level suggest that
more than 6% had used anabolic steroids (4). However, even
though we were unable either to question the participants or to
perform blood tests for steroid use as part of our study, National
Football League (NFL) players are subject to year-round testing.
Therefore, it would be very difficult for them to use these
substances.
The number of subjects with thickened ventricular walls is
correctly shown in the histogram of Figure 2 of our report.
Actually, 30% (47 of 156 subjects) had a wall thickness 13 mm.
The statement in the Discussion section of our report that “six
percent of the football players in our series had a wall thickness in
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